Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
Clinical trial NCT03521830 · RECRUITING
Trial details
- NCT number
- NCT03521830
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2027-07-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.